Economic Burden of Parkinson's Disease: A Multinational, Real-World, Cost-of-Illness Study.

ABSTRACT:

Background

Parkinson's disease is now one of the fastest-growing neurodegenerative disorders in the developed world, with an increasing prevalence and associated socioeconomic costs. Progression of the disease leads to a gradual deterioration in patients' quality of life, despite optimal treatment, and both medical and societal needs increase, often with the assistance of paid and/or unpaid caregivers.

Objective

We aimed to quantify the incremental economic burden of Parkinson's disease by disease severity in a real-world setting across differing geographic regions.

Methods

Demographics, clinical characteristics, health status, patient quality of life, caregiver burden, and healthcare resource utilization data were drawn from the Adelphi Parkinson's Disease Specific P

SUBMITTER: Chaudhuri KR 

PROVIDER: S-EPMC10928026 | biostudies-literature | 2024 Mar

REPOSITORIES: biostudies-literature